Invests primarily in equity securities of companies in health sciences and related industries. Focuses on companies in health care equipment and supplies. Now — the numbers.
The stock trades 16% below its peak. The market has trimmed its expectations for the company.
It pays out $9.65 per share each year — regular cash for whoever holds the stock.
This is a fund, not a company — there are no company accounts here to point to a risk. What it holds is what it is.
We grade companies — revenue, margins, balance sheets. This is a fund, so there is no report card to give. That is not a low grade; it is a different kind of thing.
One-line summary: a basket, not a business. Judge it by what it holds.